Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hyperostosis-Hyperphosphatemia Syndrome (Hhs): Report of Two Cases With a Recurrent Mutation and Review of the Literature Publisher Pubmed



Ghafourifard S1 ; Abbasi F2 ; Azizi F1 ; Javaheri M1 ; Mehdizadeh M3 ; Setoodeh A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Growth and Development Research Center, Children Medical Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Children Medical Hospital, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Endocrine and Metabolic Division, Children Medical Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Pediatric Endocrinology and Metabolism Published:2015


Abstract

Hyperostosis-hyperphosphatemia syndrome (HHS) is a rare autosomal recessive metabolic disorder caused by mutations in the GALNT3 and FGF23 genes. The main features of this disorder include painful swelling of long bones, increased renal reabsorption of phosphate but normal renal function and vitamin D and parathormone levels. Previously, we reported a novel missense mutation in the FGF23 gene in a patient suffering from HHS. In the present report, we demonstrated the same mutation (c.471C>A) in two other cases of HHS with similar clinical manifestations. As this nucleotide change has not been reported previously, it can be a population specific mutation in Iran that can facilitate carrier testing and prenatal diagnosis of HHS.
Related Docs